Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients
- PMID: 2493323
- DOI: 10.1007/BF02556561
Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients
Abstract
Combination therapy with the biologically active (1-38) human parathyroid hormone peptide and calcitonin using pulsatile and sequential activation of the skeleton for 14 months in patients with low-turnover osteoporosis resulted in an increase in trabecular bone mass. These favorable responses were observed without any significant changes in cortical (forearm) bone mass content.
Similar articles
-
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ. 1990 Aug 11;301(6747):314-8. doi: 10.1136/bmj.301.6747.314. BMJ. 1990. PMID: 2393738 Free PMC article.
-
Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.Bone Miner. 1991 Jul;14(1):67-83. doi: 10.1016/0169-6009(91)90103-7. Bone Miner. 1991. PMID: 1868270 Clinical Trial.
-
[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].Med Klin (Munich). 1990 Feb 15;85(2):82-6. Med Klin (Munich). 1990. PMID: 2319988 German.
-
[Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].Med Klin (Munich). 1989 Oct 15;84(10):488-98. Med Klin (Munich). 1989. PMID: 2685534 Review. German. No abstract available.
-
Osteoporosis: how should it be treated?J Investig Med. 2006 Apr;54(3):114-22. doi: 10.2310/6650.2006.05037. J Investig Med. 2006. PMID: 16948394 Review.
Cited by
-
Estrogen receptors and biologic response in rat parathyroid tissue and C cells.J Clin Invest. 1992 Dec;90(6):2434-8. doi: 10.1172/JCI116134. J Clin Invest. 1992. PMID: 1469095 Free PMC article.
-
Trabecular bone structure in patients with primary hyperparathyroidism.Virchows Arch. 1995;426(2):127-34. doi: 10.1007/BF00192633. Virchows Arch. 1995. PMID: 7757282
-
Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.Calcif Tissue Int. 1995 Mar;56(3):181-5. doi: 10.1007/BF00298606. Calcif Tissue Int. 1995. PMID: 7750020 Clinical Trial.
-
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ. 1990 Aug 11;301(6747):314-8. doi: 10.1136/bmj.301.6747.314. BMJ. 1990. PMID: 2393738 Free PMC article.
-
Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging.Drugs Aging. 1991 Sep-Oct;1(5):405-23. doi: 10.2165/00002512-199101050-00007. Drugs Aging. 1991. PMID: 1794028 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical